Atlas FDA

MNG

7 FDA 510(k) clearances · Product code

176 daysmedian time to decision
391 days90th percentile
7clearances measured

FDA profile

Official device name
External Urethral Occluder, Urinary Incontinence-Control, Female
Device class
Class I (low risk)
Regulation
21 CFR 876.5160
Medical specialty
Gastroenterology, Urology
FDA definition
Intended to prevent or decrease episodes of urine leakage in women with stress incontinence. Occluder is applied to urinary meatus through suction or tape, which creates a barrier for urine leakage. Occluding device such as a cap, suction cup, or foam pad. May include adhesive gel or ointment.
Adverse events (MAUDE)
1997: 49 · 1999: 2 · 2000: 15 · 2001: 10 · 2002: 5 · 2003: 4
Reports received by FDA, not confirmed device causation - volume tracks device popularity as much as risk.
Sort:Newest firstOldest first

Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free

RecordFirmDate
ORTHO CONTROL FEMALE URINARY CONTROL DEVICE (K010365)Personal Products Co.2001-04-30
RESTORE (AKA RE/STOR) (K983164)Nebl, Inc.1999-03-05
UROMED PATCH (K974600)Uromed Corp.1998-03-31
FEMASSIST FLEXIBLE (K974645)Insight Medical Corp.1998-02-12
RESTORE (A.K.A. CAPSURE) (K971359)Nebl, Inc.1997-11-14
FEMASSIST URINARY DEVICE (K963858)Insight Medical Corp.1997-10-21
MINIGUARD (K954215)Advanced Surgical Intervention, Inc.1996-05-08

Track MNG automatically

Every clearance here is in the API, with alerts when new ones post.